NHS England consultation on over-the-counter medicines is now open
NHS England has launched a consultation on proposals to cut [...]
US Food and Drug Administration approves frontline cabozantinib for advanced kidney cancer
Cabozantinib (Cabometyx) has been granted approval by the US Food [...]
Pembrolizumab investigated as adjuvant therapy for renal cell carcinoma
Immunotherapy has been a major breakthrough in the treatment of [...]
European guidelines for the management of metastatic renal cell carcinoma to be updated
The European Association of Urology (EAU) guidelines are to be [...]
One in five cancer patients waits too long for a diagnosis
An article in The Times reports that least a fifth of [...]
Nivolumab-ipilimumab combination granted priority review by FDA
The Food and Drug Adminitration in the US has granted [...]
Management of bone metastases in renal cell carcinoma
The following video from Practise Update is an interview with [...]
Nearly 40% of cancer deaths could be prevented by lifestyle changes
An article in The Daily Mail reports on research that suggests [...]
Non-steroidal anti-inflammatory drugs may improve survival in kidney cancer
A new study published in the International Journal of Cancer suggests [...]
Adjuvant therapy for renal cell carcinoma
The following article is a good review of the data [...]
